Axion BioSystems
PrivateLast Round
Buyout/LBO
Jul 16, 2021
Total Funding Raised
$25,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Axion BioSystems operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was a VC Round in May 2016.
Axion BioSystems is a life science tools company that develops and markets microelectrode array (MEA) and impedance-based systems for non-invasive, real-time study of cells for academic and biopharma customers.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axion BioSystems Comparables
Compare Axion BioSystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 3Brain AG | 82% | |
| Sophion Bioscience | 81% | |
| MaxWell Biosystems | 81% |
For institutional investors. Book with your work email.
Axion BioSystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Jul 16, 2021 | ||||
| VC Round | May 16, 2016 | ||||
| VC Round | Apr 1, 2012 | ||||
| Grant | Jun 1, 2007 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Axion BioSystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Georgia Research Alliance | Grant, VC Round |
| Summa Equity | Buyout/LBO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 39, 7.8x the trailing average.
- Jul 13, 2026
Open roles increased from 0 to 15, representing 12% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 30, 2026
Axion BioSystems launches Synexus, a platform for disease research and therapeutic development that brings single-cell resolution to high-throughput, label-free workflows, on Nov 2nd '26.
For institutional investors. Book with your work email.
Axion BioSystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Axion BioSystems's valuation, stock price, and market status.
Is Axion BioSystems a public or private company?
Axion BioSystems is a private company.
What is the current stock price of Axion BioSystems?
Axion BioSystems is a private company, so its shares have no public market price. Caplight tracks Axion BioSystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Axion BioSystems worth (valuation)?
Valuation information for Axion BioSystems is not publicly available.
Can I buy Axion BioSystems stock?
Axion BioSystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Axion BioSystems's last funding round?
Axion BioSystems's most recent funding round was Buyout/LBO on July 16, 2021.
Who are the main investors in Axion BioSystems?
Key investors in Axion BioSystems include Georgia Research Alliance, Summa Equity.
Will Axion BioSystems IPO soon?
No public IPO plans have been announced for Axion BioSystems.
How can I track Axion BioSystems secondary market activity?
Caplight tracks bids, offers, and trades in Axion BioSystems's shares on secondary markets.